Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Accepts healthy volunteers

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children

ClinicalTrials.gov ID: NCT00767416

Public ClinicalTrials.gov record NCT00767416. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:39 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Immunogenicity, and Viral Shedding of MEDI-559, a Live Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus in Healthy 1 to <24 Month-Old Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to describe the 28-day post-final dose safety and tolerability of three doses of MEDI-559 at 10\^5 FFU when administered to healthy RSV seronegative children 1 to \<24 months of age.

Study identification

NCT ID
NCT00767416
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
MedImmune LLC
Industry
Enrollment
116 participants

Conditions and interventions

Conditions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
1 Month to 23 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2008 (Type not available)
Primary completion
Dec 2011 (Actual)
Completion
Dec 2011 (Actual)
Last update posted
Jul 20, 2016

2008 – 2011

United States locations

U.S. sites
75
U.S. states
27
U.S. cities
65
Facility City State ZIP Site status
Research Site Greenville Alabama 36037 —
Research Site Huntsville Alabama 35802 —
Research Site Mobile Alabama 36608 —
Research Site Conway Arkansas 72034 —
Research Site Little Rock Arkansas 72202 —
Research Site Little Rock Arkansas 72205 —
Research Site Anaheim California 92804 —
Research Site Cypress California 90630 —
Research Site Downey California 90241 —
Research Site Huntington Beach California 92647 —
Research Site Lakewood California 90712 —
Research Site Long Beach California 90806 —
Research Site Los Angeles California 90015 —
Research Site Los Angeles California 90024 —
Research Site Paramount California 90723 —
Research Site San Diego California 92103 —
Research Site Santa Ana California 92705 —
Research Site Thornton Colorado 80223 —
Research Site Hartford Connecticut 06106 —
Research Site Washington D.C. District of Columbia 20058 —
Research Site Miami Florida 33142 —
Research Site Miami Florida 33155 —
Research Site Orange City Florida 32763 —
Research Site Tampa Florida 33606 —
Research Site Dalton Georgia 30721 —
Research Site Chicago Illinois 60614 —
Research Site Fishers Indiana 46037 —
Research Site New Albany Indiana 47150 —
Research Site South Bend Indiana 46601 —
Research Site Ames Iowa 50010 —
Research Site Bardstown Kentucky 40004 —
Research Site Lexington Kentucky 40503 —
Research Site Lexington Kentucky 40509 —
Research Site Louisville Kentucky 40202 —
Research Site Louisville Kentucky 40207 —
Research Site Paducah Kentucky 42003 —
Research Site Metarie Louisiana 70006 —
Research Site Fredrick Maryland 21215 —
Research Site Boston Massachusetts 02111 —
Research Site Fall River Massachusetts 02724 —
Research Site Bridgeton Missouri 63044 —
Research Site Kansas City Missouri 64132 —
Research Site Omaha Nebraska 68131 —
Research Site Omaha Nebraska 68134 —
Research Site Brooklyn New York 11219 —
Research Site Endwell New York 13760 —
Research Site Stony Brook New York 11794 —
Research Site Syracuse New York 13210 —
Research Site Cleveland Ohio 44109 —
Research Site Cleveland Ohio 44121 —
Research Site Huber Heights Ohio 45424 —
Research Site Norman Oklahoma 73071 —
Research Site Tulsa Oklahoma 74127 —
Research Site Warwick Rhode Island 02886 —
Research Site Spartanburg South Carolina 29303 —
Research Site Franklin Tennessee 37067 —
Research Site Jackson Tennessee 38305 —
Research Site Johnson City Tennessee 37604 —
Research Site Kingsport Tennessee 37660 —
Research Site Corpus Christi Texas 78414 —
Research Site Houston Texas 77036 —
Research Site Houston Texas 77055 —
Research Site San Angelo Texas 76904 —
Research Site San Antonio Texas 78205 —
Research Site San Antonio Texas 78229 —
Research Site San Antonio Texas 78258 —
Research Site Tomball Texas 77375 —
Research Site Layton Utah 84041 —
Research Site St. George Utah 84790 —
Research Site Syracuse Utah 84075 —
Research Site Charlottesville Virginia 22902 —
Research Site Colonial Heights Virginia 23834 —
Research Site Midlothian Virginia 23113 —
Research Site Richmond Virginia 23219 —
Research Site Walla Walla Washington 99362 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00767416, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 20, 2016 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00767416 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →